UY29266A1 - Compuestos de piridazinona - Google Patents

Compuestos de piridazinona

Info

Publication number
UY29266A1
UY29266A1 UY29266A UY29266A UY29266A1 UY 29266 A1 UY29266 A1 UY 29266A1 UY 29266 A UY29266 A UY 29266A UY 29266 A UY29266 A UY 29266A UY 29266 A1 UY29266 A1 UY 29266A1
Authority
UY
Uruguay
Prior art keywords
compounds
piridazinona
hepatitis
treatment
pharmaceutical compositions
Prior art date
Application number
UY29266A
Other languages
English (en)
Inventor
Stephen E Webber
Yuefen Zhou
Liansheng Li
Original Assignee
Anadys Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anadys Pharmaceuticals Inc filed Critical Anadys Pharmaceuticals Inc
Publication of UY29266A1 publication Critical patent/UY29266A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Abstract

La invención se refiere a compuestos de piridazinona y composiciones farmacéuticas que los contienen para el tratamiento de infecciones por el virus de hepatitis C.
UY29266A 2004-12-17 2005-12-20 Compuestos de piridazinona UY29266A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63661604P 2004-12-17 2004-12-17

Publications (1)

Publication Number Publication Date
UY29266A1 true UY29266A1 (es) 2006-07-31

Family

ID=36588590

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29266A UY29266A1 (es) 2004-12-17 2005-12-20 Compuestos de piridazinona

Country Status (21)

Country Link
US (1) US7425552B2 (es)
EP (1) EP1824847A2 (es)
JP (1) JP2008526687A (es)
KR (1) KR20070100743A (es)
CN (1) CN101137651A (es)
AP (1) AP2007004040A0 (es)
AR (1) AR054214A1 (es)
AU (1) AU2005316396A1 (es)
CA (1) CA2589527A1 (es)
CR (1) CR9204A (es)
EA (1) EA200701297A1 (es)
GT (1) GT200500373A (es)
IL (1) IL183510A0 (es)
MX (1) MX2007007264A (es)
NO (1) NO20073105L (es)
PA (1) PA8657001A1 (es)
PE (1) PE20060871A1 (es)
SV (1) SV2006002347A (es)
TW (1) TW200635596A (es)
UY (1) UY29266A1 (es)
WO (1) WO2006066079A2 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR054214A1 (es) 2004-12-17 2007-06-13 Anadys Pharmaceuticals Inc Compuestos derivados de 1, 1 - dioxotiadiazina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de la infeccion por el virus de la hepatitis c.
ES2600460T3 (es) 2005-05-10 2017-02-09 Intermune, Inc. Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés
WO2007150001A1 (en) 2006-06-22 2007-12-27 Anadys Pharmaceuticals, Inc. Pyrro[1,2-b]pyridazinone compounds
US20080090814A1 (en) * 2006-06-22 2008-04-17 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
TW200840572A (en) 2006-12-12 2008-10-16 Anadys Pharmaceuticals Inc 5,6-dihydro-1H-pyridin-2-one compounds
WO2008073987A1 (en) * 2006-12-12 2008-06-19 Anadys Pharmaceuticals, Inc. Saturated fused [1,2-b] pyridazinone compounds
US20080188466A1 (en) * 2006-12-21 2008-08-07 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
WO2008082725A1 (en) * 2006-12-29 2008-07-10 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
US20080227774A1 (en) * 2007-03-15 2008-09-18 Frank Ruebsam 5,5-disubstituted-indolizinone compounds
UA100120C2 (en) 2007-04-03 2012-11-26 Анадис Фармасьютикалз, Инк. 5,6-dihydro-1h-pyridin-2-one compounds
US8258116B2 (en) 2007-05-04 2012-09-04 Vertex Pharmaceuticals Incorporated Combination therapy for the treatment of HCV infection
US20080292588A1 (en) * 2007-05-17 2008-11-27 Anadys Pharmaceuticals, Inc. 1-methyl-benzo[1,2,4]thiadiazine 1-oxide derivatives
ITMI20071012A1 (it) * 2007-05-18 2008-11-19 St Microelectronics Srl Dispositivo di memoria migliorato a veloce programmazione
US7834009B2 (en) * 2007-08-27 2010-11-16 Anadys Pharmaceuticals, Inc. 4-hydroxy-5,6-dihydro-1H-pyridin-2-one compounds
CA2726588C (en) 2008-06-03 2019-04-16 Karl Kossen Compounds and methods for treating inflammatory and fibrotic disorders
WO2009152166A1 (en) 2008-06-10 2009-12-17 Anadys Pharmaceuticals, Inc. [1,2,4]thiadiazine 1,1-dioxide compounds
TW201026675A (en) * 2008-10-09 2010-07-16 Anadys Pharmaceuticals Inc 5,6-dihydro-1H-pyridin-2-one compounds
TWI480272B (zh) * 2008-10-09 2015-04-11 Anadys Pharmaceuticals Inc 藉由５，６－二氫－１ｈ－吡啶－２－酮與一或多種其他抗病毒化合物的組合物抑制ｃ型肝炎病毒的方法
WO2010082050A1 (en) 2009-01-16 2010-07-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Macrocyclic and 7-aminoalkyl-substituted benzoxazocines for treatment of hepatitis c infections
WO2011045271A1 (de) 2009-10-15 2011-04-21 Bayer Cropscience Ag Herbizid wirksame heterocyclylsubstituierte pyridazinone
EP2493476A4 (en) * 2009-10-28 2013-06-19 Anadys Pharmaceuticals Inc DEUTERATED 5,6-DIHYDRO-1H-PYRIDINE-2-ON COMPOUNDS
MX2012007076A (es) 2009-12-18 2012-07-20 Boehringer Ingelheim Int Terapia combinada de hcv.
WO2012158271A1 (en) 2011-04-06 2012-11-22 Anadys Pharmaceuticals, Inc. Bridged polycyclic compounds as antiviral agents
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2014121416A1 (en) 2013-02-07 2014-08-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
WO2014121418A1 (en) 2013-02-07 2014-08-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
WO2014121417A1 (en) 2013-02-07 2014-08-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
CN110452216B (zh) 2014-04-02 2022-08-26 英特穆恩公司 抗纤维化吡啶酮类
PE20211761A1 (es) * 2014-04-29 2021-09-07 Fmc Corp Herbicidas de piridazinona
JP6428951B2 (ja) * 2015-12-07 2018-11-28 Dic株式会社 重合性化合物の製造方法
CN105999097A (zh) * 2016-07-08 2016-10-12 王恩禄 一种***的中药组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ504021A (en) * 1997-10-17 2003-04-29 Systemic Pulmonary Delivery Lt Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
WO2001085172A1 (en) 2000-05-10 2001-11-15 Smithkline Beecham Corporation Novel anti-infectives
US20060003346A1 (en) 2000-08-11 2006-01-05 Ashok Amin Method for treating hepatitis
AR036081A1 (es) 2001-06-07 2004-08-11 Smithkline Beecham Corp Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos
AU2002365198A1 (en) 2001-10-30 2003-07-30 Smithkline Beecham Corporation Novel anti-infectives
US7601709B2 (en) 2003-02-07 2009-10-13 Enanta Pharmaceuticals, Inc. Macrocyclic hepatitis C serine protease inhibitors
US7439246B2 (en) 2004-06-28 2008-10-21 Bristol-Myers Squibb Company Fused heterocyclic kinase inhibitors
MX2007002238A (es) 2004-08-23 2007-04-20 Hoffmann La Roche Compuestos heterociclicos antiviricos.
AR054214A1 (es) 2004-12-17 2007-06-13 Anadys Pharmaceuticals Inc Compuestos derivados de 1, 1 - dioxotiadiazina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de la infeccion por el virus de la hepatitis c.
BRPI0607533A2 (pt) 2005-04-21 2009-09-15 Nippon Shinyaku Co Ltd derivado de ftalazinona, composição farmacêutica, inibidor de fosfodiesterase do tipo 4,supressor da produção de tnf-alfa, agente preventivo ou terapêutico, preparado externo, bem como uso do referido derivado
KR20070116682A (ko) 2005-05-04 2007-12-10 에프. 호프만-라 로슈 아게 헤테로사이클릭 항바이러스성 화합물
WO2007150001A1 (en) 2006-06-22 2007-12-27 Anadys Pharmaceuticals, Inc. Pyrro[1,2-b]pyridazinone compounds

Also Published As

Publication number Publication date
PE20060871A1 (es) 2006-09-04
WO2006066079A3 (en) 2006-12-14
EP1824847A2 (en) 2007-08-29
GT200500373A (es) 2006-10-02
AU2005316396A1 (en) 2006-06-22
CN101137651A (zh) 2008-03-05
EA200701297A1 (ru) 2007-12-28
TW200635596A (en) 2006-10-16
KR20070100743A (ko) 2007-10-11
CR9204A (es) 2007-09-06
US20060189602A1 (en) 2006-08-24
PA8657001A1 (es) 2006-08-03
NO20073105L (no) 2007-09-13
AP2007004040A0 (en) 2007-06-30
MX2007007264A (es) 2007-08-14
WO2006066079A2 (en) 2006-06-22
IL183510A0 (en) 2007-09-20
US7425552B2 (en) 2008-09-16
AR054214A1 (es) 2007-06-13
JP2008526687A (ja) 2008-07-24
SV2006002347A (es) 2006-08-25
CA2589527A1 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
UY29266A1 (es) Compuestos de piridazinona
CL2011001224A1 (es) Compuestos derivados de benzofurano-3-carboxamida; composicion farmaceutica que los comprende; y su uso en tratamiento del virus de la hepatitis c.
CL2008001005A1 (es) Compuestos derivados de azufre, inhibidores de la serina proteasa ns3 del virus de la hepatitis c; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos asociados a la proteasa de hcv.
UY30778A1 (es) Compuestos de 5,6-dihidro-1h-piridin-2-ona
CR11316A (es) Derivado de uracilo o timina para el tratamiiento de la hepatitis c.
DOP2010000052A (es) Entidades quimicas biciclicas que contienen nitrogeno para el tratamiento de infecciones virales
CL2008000959A1 (es) Compuestos derivados de 1,2,4-tiadiazina o 1,4-tiazina; composiciones farmaceuticas que los contienen; y su uso para la prevencion y/o tratamiento de infecciones producidas por el virus de la hepatitis c.
EA200800178A1 (ru) Ингибиторы вируса гепатита с (hcv)
ECSP055801A (es) Compuestos benzofuránicos, composiciones y métodos para el tratamiento y profilaxis de infecciones virales de hepatitis c y enfermedades asociadas
CU20090209A7 (es) Compuestos macrocíclicos como inhibidores de la replicación viral
PA8733401A1 (es) Compuestos de pirro[1,2-b]piridazinona
UY28581A1 (es) Compuestos nucleosidicos para el tratamiento de infecciones virales
EA200800371A1 (ru) Ингибиторы ns3 протеазы вгс
CL2008002295A1 (es) Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
CL2007003299A1 (es) Compuestos derivados de macrociclos, inhibidores del virus de la hepatitis c; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c.
CL2008003431A1 (es) Compuestos derivados de nucleosidos 2',4' sustituidos; proceso de preparacion de dichos compuestos; composicion farmaceutica que los comprende; su metodo de preparacion; y su uso para el tratamiento y/o la prevencion de cualquier condicion resultante de una infeccion por vhb, vhc o vih.
BR0305426A (pt) Compostos inibidores de ns5b polimerase de hcv, bem como composição farmacêutica compreendendo os mesmos
CU23794B7 (es) Inhibidores macrocíclicos de la replicación del virus de la hepatitis c
EA201100795A1 (ru) Фармацевтическая композиция эффективного ингибитора всг для перорального введения
GT200600327A (es) Ciclohexilaminoisoquinolona
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
DK2250163T3 (da) Hepatitis C-virusinhibitorer
CL2011000691A1 (es) Compuestos derivados de nicotinamida sustituida; composicion farmaceutica que los comprende; uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias.
ES2422556T3 (es) Tratamiento de hepatitis vírica
CL2008003511A1 (es) Compuestos derivados nucleotidicos, inhibidores de polimerasa ns5b del virus de la hepatitis c; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160606